Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.42 is 54% below its 5-year average of 18.22, near the low end of its 5-year range (8.42–59.98).
As of the fiscal period ended Tuesday, June 30, 2026. 14.51% below its 12-month average of 9.85.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.42.
QUICK RATIO (ACID-TEST)
8.42
QUICK RATIO (ACID-TEST) AVG TTM
9.85
QUICK RATIO (ACID-TEST) AVG 3Y
16.21
QUICK RATIO (ACID-TEST) AVG 5Y
18.22
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.51%
CURRENT VS 3Y AVG
-48.08%
CURRENT VS 5Y AVG
-53.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.00
median of 670 covered companies
CURRENT VS SECTOR MEDIAN
+181.04%
vs the sector median at left
Cullinan Therapeutics, Inc.
Market Cap
$1.08B
Quick Ratio (Acid-Test)
8.42
TTM Avg
9.85
3Y Avg
16.21
5Y Avg
18.22
Market Cap
$1.08B
Quick Ratio (Acid-Test)
8.13
TTM Avg
7.23
3Y Avg
6.69
5Y Avg
8.24
Market Cap
$1.06B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$1.04B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
Market Cap
$1.05B
Quick Ratio (Acid-Test)
16.35
TTM Avg
49.13
3Y Avg
36.31
5Y Avg
29.96
Market Cap
$1.10B
Quick Ratio (Acid-Test)
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.08B | 8.42 | 9.85 | 16.21 | 18.22 |
| IRadimed Corporation (IRMD)vs › | $1.08B | 8.13 | 7.23 | 6.69 | 8.24 |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | 0.81 | 2.16 | 2.71 | 2.89 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | 5.85 | 6.12 | 6.56 | 10.14 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.05B | 16.35 | 49.13 | 36.31 | 29.96 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | 11.59 | 21.25 | 14.51 | 14.51 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | 1.98 | 1.08 | 1.74 | 1.96 |
| Immatics N.V. (IMTX)vs › | $1.03B | 7.54 | 10.49 | 6.85 | 5.34 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.71 | 2.54 | 2.42 | 2.25 |
Quick Ratio
8.42
Excludes inventory
Current Ratio
8.42
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.42 |
| 2026-03-31 | 10.28 |
| 2025-12-31 | 10.25 |
| 2025-09-30 | 10.45 |
| 2025-06-30 | 9.83 |
| 2025-03-31 | 11.62 |
| 2024-12-31 | 13.53 |
| 2024-09-30 | 24.46 |
| 2024-06-30 | 28.87 |
| 2024-03-31 | 20.33 |
| 2023-12-31 | 17.07 |
| 2023-09-30 | 20.33 |
| 2023-06-30 | 25.32 |
| 2023-03-31 | 15.25 |
| 2022-12-31 | 21.09 |
| 2022-09-30 | 21.47 |
| 2022-06-30 | 10.04 |
| 2022-03-31 | 18.68 |
| 2021-12-31 | 25.25 |
| 2021-09-30 | 41.82 |
| 2021-06-30 | 59.98 |
| 2021-03-31 | 45.21 |
| 2020-12-31 | 14.82 |
| 2020-09-30 | 28.68 |
| 2020-06-30 | 17.54 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 39.67 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
